Welcome back for another week of What’s Next, where we report on the intersection of law and technology. Following a series of nightmarish reproductive malpractice suits in California, Dov Fox, director of the University of San Diego’s Center for Health Law Policy and Bioethics, takes us through how challenging it can be for patients to get justice. Plus, we prophesize the future of blockchain-based offerings after the first U.S. Securities and Exchange Commission-approved token sale under Regulation A+. And here’s what the legal community thinks about the Federal Trade Commission’s $5 billion settlement with Facebook. Let’s chat: Email me at [email protected] and follow me on Twitter at @a_lancaster3.
![](https://images.law.com/contrib/content/uploads/sites/292/2019/07/unnamed-41.jpg)
The Law Has No Answer for a High-Tech Baby Boom
After thousands of dollars of in vitro fertilization treatments and nine months of pregnancy, a New York couple was forced to give up the twins they birthed. It turns out CHA Fertility Center, the Los Angeles clinic the couple sought IVF treatment at, mixed up the embryos of three patients, resulting in two of the couples having to give up children to their genetic parents. Now, those parents are suing.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]